Research Interests: Prostate cancer, ovarian cancer, molecular epidemiology,obesity, blood pressure, hypertension, diabetes, birth outcome.
Principal Investigator: Molecular Epidemiology of Prostate Cancer in Tobagonians (1999-2011) NCI, NIH; Inflammation and Ovarian Cancer (2009-2011) NCI, NIH; SHARE India University Pittsburgh Population and Intervention Research Training (2011-2016), Fogarty International Center, NIH; Empowering Indian Researchers with Computational Modeling Tools (2015-2018), Fogarty International Center, NIH
1961 | Wellesley College, Wellesley, AB
1980 | Johns Hopkins University, Baltimore, MPH
1984 | University of Pittsburgh, Pittsburgh, PA | Epidemiology | PhD
1985 | University of Pittsburgh, Pittsburgh, PA | Epidemiology | Post-Doctoral Fellowship
Co-taught Introduction to Molecular Epidemiology for 15 years�
| Patrick AL, Bunker CH, Nelson JB, Dhir R, Wheeler VW, Zmuda JM, Richard JR, Belle AC, Kuller LH. Argument for prostate cancer screening in populations of African-Caribbean origin. BJU International. 2014 Jul 21. PMID:25046681. PMCID:PMC4406859. doi:10.1111/bju.12869. |
|
Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B. (2012, August). Use of fertility drugs and risk of ovarian cancer: results from a U.S-based case control study. Cancer Epidemiol Biomarkers Prev. 21(8):1282-92. Epub 2012 Jun 15. PMID: 22707710; PMCID:PMC3415595 |
|
Lo-Ciganic W-H, Zgibo JC, Bunker CH, Moysich KB, Edwards, RP, Ness RB. (2012, March) Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian Cancer. Epidemiology 2012; 23(2):311-19. PMID: 22252409; PMCID:PMC3454462 |
|
McDonald AC, Jenkins FJ, Bunker CH, Wilson JW, Patrick AL, Weissfeld JL. (2011, Dec). A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago. Infectious Agents and Cancer 2011; 6:25. PMID: 22151996; PMC3248833 |
|
Beason, T. S., Bunker, C. H., Zmuda, J. M., Wilson, J. W., Patrick, A. L., Wheeler, V. W., Weissfeld, J. L. (2011, May). ADRB2 gene variants, dual-energy x-ray absorptiometry body composition, and hypertension in Tobago men of African descent. Metabolism: clinical and experimental, 60(5), 698-705. PMCID: PMC2992095 |
|
Langevin, S. M., Stone, R. A., Bunker, C. H., Grandis, J. R., Sobol, R. W., Taioli, E. (2010, May). MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis, 31(5), 864-70. PMCID: PMC2864416 |
|
Farhat, G. N., Taioli, E., Cauley, J. A., Zmuda, J. M., Orwoll, E., Bauer, D. C., Wilt, T. J., Hoffman, A. R., Beer, T. M., Shikany, J. M., Daniels, N., Chan, J., Fink, H. A., Barrett-Connor, E., Parsons, J. K., Bunker, C. H., Osteoporotic Fractures in Men (MrOS) Study Group (2009, January). The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study. Cancer epidemiology, biomarkers & prevention : 18(1), 148-54. PMCID: PMC2651680 |
|
Okobia, M. N., Bunker, C. H., Garte, S. J., Zmuda, J. M., Ezeome, E. R., Anyanwu, S. N., Uche, E. E., Osime, U., Ojukwu, J., Kuller, L. H., Ferrell, R. E., Taioli, E. (2009). Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study. Infectious agents and cancer, 4, S12. PMCID: PMC2638457 |
|
Shea, P. R., Ishwad, C. S., Bunker, C. H., Patrick, A. L., Kuller, L. H., Ferrell, R. E. (2008, March 1). RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans. The Prostate, 68(4), 354-9. |
|
Bunker, C. H., McDonald, A. C., Evans, R. W., de la Rosa, N., Boumosleh, J. M., Patrick, A. L. (2007). A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutrition and cancer, 57(2), 130-7. |
|
Bunker, C. H., Zmuda, J. M., Patrick, A. L., Wheeler, V. W., Weissfeld, J. L., Kuller, L. H., Cauley, J. A. (2006, October). High bone density is associated with prostate cancer in older Afro-Caribbean men: Tobago prostate survey. Cancer causes & control : CCC, 17(8), 1083-9. |
|
Bunker, C. H., Patrick, A. L., Miljkovic-Gacic, I., Konety, B. R., Belle, A., Richard, J. R., Dhir, R. (2004, April). Prostate cancer screening parameters in a high-risk African-Caribbean population. Urology, 63(4), 737-41. |
|
Hoffman, L. J., Bunker, C. H., Pellett, P. E., Trump, D. L., Patrick, A. L., Dollard, S. C., Keenan, H. A., Jenkins, F. J. (2004, January 1). Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. Journal of infectious diseases, 189(1), 15-20. |
|
Shea, P. R., Ferrell, R. E., Patrick, A. L., Kuller, L. H., Bunker, C. H. (2002, October). ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago. Human genetics, 111(4), 398-400. |
|
Bunker, C. H., Patrick, A. L., Konety, B. R., Dhir, R., Brufsky, A. M., Vivas, C. A., Becich, M. J., Trump, D. L., Kuller, L. H. (2002, August). High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev 11(8), 726-9. |
